IRadimed gains on higher prelim Q4 revenue

IRADIMED

18/01/2023 19:15

** Shares of medical device maker IRadimed Corporation
 IRMD.O  up ~8% at $32.95, hitting an over 4-month high
    ** IRMD now expects Q4 prelim revenue of about $14.9 mln, up
25% from prior year, vs previous guidance of $14.1 mln to $14.8
mln
    ** "Orders booked in the fourth quarter exceeded shipments,
again growing the backlog and providing added visibility as we
enter 2023," says CEO Roger Susi 
    ** Co sees Q1 revenue of $14.6 mln to $14.9 mln and adj
profit of $0.26 to $0.28 per share
    ** IRMD fell ~38% in 2022
 (Reporting by Yamini Kalia in Bengaluru)
 ((Yamini.kalia@thomsonreuters.com))